Pre-Series B · Biotech

Forlong Biotechnology raises $17.5m pre-Series B

Fudan Capital, Changshu Guofa Venture and Kunsheng Relay Fund participated in the oncology biotech's financing.

Forlong Biotechnology raised $17.5 million in pre-Series B financing on May 19. Participants included Fudan Capital, Changshu Guofa Venture and Kunsheng Relay Fund. The clinical-stage company develops cytokine therapies for cancer, including IL-15 and IL-18 programs.

Funding history

Pre-Series B · This round$17.5M

Sources

  1. Forlong Biotechnologyprojectstartups.com
  2. businesswire.com